During the past decade, Zhongda Hospital Southeast University conducted 174 clinical trials. In the 10-year time frame, 174 clinical trials started and 16 clinical trials were completed, i.e. on average, 9.2% percent of trials that started reached the finish line to date. In the past 5 years, 85 clinical trials started and 14 clinical trials were completed. i.e. 16.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Zhongda Hospital Southeast University" #1 sponsor was "Southeast University, China" with 49 trials, followed by "Zhongda Hospital" with 35 trials sponsored, "Janssen Research & Development, LLC" with 8 trials sponsored, "Bayer" with 6 trials sponsored and "Jianfeng Xie" with 6 trials sponsored. Other sponsors include 95 different institutions and companies that sponsored additional 70 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Zhongda Hospital Southeast University" #1 collaborator was "Zhongda Hospital" with 15 trials as a collaborator, "Baxter Healthcare Corporation" with 3 trials as a collaborator, "Guizhou Provincial People's Hospital" with 3 trials as a collaborator, "The First Affiliated Hospital of Zhengzhou University" with 3 trials as a collaborator and "The Third Xiangya Hospital of Central South University" with 3 trials as a collaborator. Other collaborators include 137 different institutions and companies that were collaborators in the rest 123 trials.

According to Clinical.Site data, the most researched conditions in "Zhongda Hospital Southeast University" are "Septic Shock" (13 trials), "Sepsis" (10 trials), "ARDS" (7 trials), "Coronary Artery Disease" (7 trials) and "Hepatocellular Carcinoma" (7 trials). Many other conditions were trialed in "Zhongda Hospital Southeast University" in a lesser frequency.

Most popular intervention types in "Zhongda Hospital Southeast University" are "Drug" (108 trials), "Device" (30 trials), "Other" (19 trials), "Procedure" (18 trials) and "Biological" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (28 trials), "Daratumumab" (4 trials), "FG-4592" (3 trials), "Guselkumab" (3 trials) and "Propofol" (3 trials). Other intervention names were less common.

The vast majority of trials in "Zhongda Hospital Southeast University" are 193 trials for "All" genders, 7 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are 77 active trials in "Zhongda Hospital Southeast University". 3 are not yet recruiting, 57 are recruiting, 16 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 68 completed trials in Zhongda Hospital Southeast University, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Zhongda Hospital Southeast University, 8 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 57 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 49 trials that are defined as “Not Applicable".